PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Gastroenterology, and Hepatology, Sections of Infectious Diseases and Tropical Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'German Center for Infection Research (DZIF), Hamburg-Lubeck-Borstel-Riems, Germany.\', \'Hämatologisch-Onkologische Praxis Eppendorf (HOPE), Hamburg, Germany.\', \'University Cancer Center Hamburg (UCCH), Hamburg, Germany.\', \'Institute of Medical Microbiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'Department of Medicine, Israelitisches Krankenhaus, Hamburg, Germany.\', \'Institute of Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'Department of Clinical Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciaa1637
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33103195
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all